ELEVATED SERUM E-SELECTIN IN PATIENTS WITH LIVER METASTASES OF COLORECTAL-CANCER

Citation
Bm. Wittig et al., ELEVATED SERUM E-SELECTIN IN PATIENTS WITH LIVER METASTASES OF COLORECTAL-CANCER, European journal of cancer, 32A(7), 1996, pp. 1215-1218
Citations number
16
Categorie Soggetti
Oncology
Journal title
ISSN journal
09598049
Volume
32A
Issue
7
Year of publication
1996
Pages
1215 - 1218
Database
ISI
SICI code
0959-8049(1996)32A:7<1215:ESEIPW>2.0.ZU;2-L
Abstract
E-selectin, an endothelial cell adhesion molecule, mediates the initia l step of leucocyte adhesion to activated vascular endothelium. The so luble isoform of E-selectin promotes angiogenesis in rat cornea. In th e present study, we investigated whether leucocyte adhesion and angiog enesis are also involved in tumour progression and metastasis of color ectal cancer. Therefore, we determined the level of circulating solubl e E-selectin in serum samples of 38 patients with colorectal cancer; 2 0 patients with non-metastatic and 18 patients with metastatic disease . Median levels of soluble E-selectin were found to be significantly h igher in metastatic tumour disease (88.7 ng/ml, range 25-203 ng/ml) th an in healthy controls (34.9 ng/ml, range 15-59 ng/ml, P=0.01), in pat ients with primary tumours or with local recurrences (39.5 ng/ml, rang e 22-100 ng/ml). Furthermore, there was no correlation with the serum level of C-reactive protein, fibrinogen or tumour necrosis factor alph a suggesting that the elevation of E-selectin is independent of inflam mation in tumour patients. Therefore, we propose that elevated soluble E-selectin may reflect increased neovascularisation in metastatic tum our tissue. Copyright (C) 1996 Elsevier Science Ltd.